SCHEMBL480430

SCHEMBL480430

CCC(Cc1ccccc1)(C(=O)c1ccc(OC)c(OC)c1)N(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.53
BCHE P06276 5/20 0.53
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HPGD P15428 1/20 0.48
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA7 P43166 1/20 0.46
TPMT P51580 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
LMNA P02545 1/20 0.45
SMPD1 P17405 1/20 0.44
HDAC1 Q13547 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29421022 1.00 ACHE (0.53) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL21706301 0.91 ACHE (0.45) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL9315365 0.91 ACHE (0.51) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL8776056 0.90 ACHE (0.42) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL8176376 0.89 HPGD (0.47) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL9316355 0.89 CTNNB1 (0.50) ACHEBCHEALDH1A1MAPTCA12
SCHEMBL8179111 0.88 HPGD (0.46) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL8175821 0.88 HPGD (0.46) ACHEBCHENPC1RAB9ASMN1; SMN2
SCHEMBL8898433 0.88 OPRM1 (0.53) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL4652464 0.88 ACHE (0.47) ACHEBCHESMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 807 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1988956-B Process for the photoactivation and use of a catalyst by an inverted two-stage procedure CIBA SC HOLDING AG 2012-10-03 CN claimed
EP-1910425-B1 PHOTOPOLYMERISABLE SYSTEMS CONTAINING LOW-EXTRACTABLE AND LOW-VOLATILE COINITIATORS LAMBERTI SPA (IT) 2011-05-25 EP claimed
US-7851029-B2 Photopolymerisable systems containing low-extractable and low-volatile coinitiators LAMBERTI SPA (IT) 2010-12-14 US claimed
US-20080213502-A1 Photopolymerisable Systems Containing Low-Extractable and Low-Volatile Coinitiators IGM RESINS ITALIA S.R.L. (IT) 2008-09-04 US claimed
JP-2008506826-A 2008-03-06 JP claimed
US-20070249484-A1 Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure CIBA SPECIALTY CHEMICALS CORP. 2007-10-25 US claimed
CN-1988956-A Process for the photoactivation and use of a catalyst by an inverted two-stage procedure CIBA SC HOLDING AG (CH) 2007-06-27 CN claimed
EP-1789188-A2 PROCESS FOR THE PHOTOACTIVATION AND USE OF A CATALYST BY AN INVERTED TWO-STAGE PROCEDURE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-05-30 EP claimed
WO-2006008251-A2 PROCESS FOR THE PHOTOACTIVATION AND USE OF A CATALYST BY AN INVERTED TWO-STAGE PROCEDURE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-01-26 WO claimed
US-20260146162-A1 PROCESS FOR PROVIDING LOW GLOSS COATINGS COVESTRO (NETHERLANDS) B.V. (NL) 2026-05-28 US disclosed
EP-4743828-A1 PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING BASF SE (DE) 2026-05-20 EP disclosed
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS BASF SE (DE) 2026-05-14 US disclosed
US-12612534-B2 Radical-curable composition COVESTRO (NETHERLANDS) B.V. (NL) 2026-04-28 US disclosed
EP-3584242-B1 FLUORENYLAMINOKETONE PHOTOINITIATOR, PREPARATION METHOD THEREOF AND UV PHOTOCURABLE COMPOSITION CONTAINING SAME CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD (CN) 2026-04-08 EP disclosed
EP-0284561-B1 ALPHA-AMINOACETOPHENONES AS PHOTO INITIATORS CIBA-GEIGY AG (CH) 1993-05-12 EP disclosed
US-5192642-A Photoinitiators for addition photopolymerization, coatings CIBA-GEIGY CORPORATION (US) 1993-03-09 US disclosed
EP-0485334-A2 Photopolymerizable compositions TOKYO OHKA KOGYO CO., LTD. (JP) 1992-05-13 EP disclosed
US-5077402-A For photocuring pigmented systems; printing inks, lacquers CIBA-GEIGY CORPORATION (US) 1991-12-31 US disclosed
US-5068371-A Photoinitiators for polymerization CIBA-GEIGY CORPORATION (US) 1991-11-26 US disclosed
EP-0284561-A2 Alpha-aminoacetophenones as photo initiators CIBA-GEIGY AG (CH) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132298-A1 A METHOD FOR PRODUCING INTERFERENCE ELEMENTS COPE, COPB2, C9 ACHE 3837/4885BCHE 4123/4885NPC1 1335/4885
US-20260146162-A1 PROCESS FOR PROVIDING LOW GLOSS COATINGS RAD51, UNG, OGG1 ACHE 3503/4885BCHE 3929/4885NPC1 3084/4885
US-20070249484-A1 Process for the Photoactivation and use of a Catalyst by an Inverted Two-Stage Procedure INF2, CRY2, CCNT2 ACHE 888/4885BCHE 2040/4885NPC1 3647/4885
US-12612534-B2 Radical-curable composition APOB, MAT2B, GLO1 ACHE 2068/4885BCHE 3086/4885NPC1 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.